TerminatedPhase 1NCT04700267
A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus
Studying Systemic lupus erythematosus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Galapagos NV
- Principal Investigator
- Catherine Vincent, MD, M.DGalapagos NV
- Intervention
- GLPG3970 film-coated tablet(drug)
- Enrollment
- 11 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2020 – 2021
Study locations (14)
- Medical center Medconsult Pleven, Pleven, Bulgaria
- UMHAT-Plovdiv AD, Plovdiv, Bulgaria
- UMHAT Sv. Ivan Rilski EAD, Sofia, Bulgaria
- ARENSIA Exploratory Medicine Phase I Unit, Chisinau, Moldova
- Szpital Uniwersytecki nr 2 im.dr J. Biziela, Bydgoszcz, Poland
- Centrum Medyczne Plejady, Krakow, Poland
- Medycyna Kliniczna, Warsaw, Poland
- FutureMeds sp. Z o. o., Wroclaw, Poland
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Medical Centre of Ltd Liability Comp, Kyiv, Ukraine
- Multidisciplinary Medical Center of Odesa National Medical University, Odesa, Ukraine
- N.I.Pirogov Vinnytsia Reg Council, Vinnytsia, Ukraine
- SRI of Invalid Rehabilitation, Vinnytsia, Ukraine
- LLC Suchasna klinika, Zaporizhzhia, Ukraine
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04700267 on ClinicalTrials.govOther trials for Systemic lupus erythematosus
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07107659Safety and Efficacy of ONT01 in LupusHospital for Special Surgery, New York
- RECRUITINGNANCT07558850Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune DiseasesThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGNCT06948110Deciphering the Genetic Architecture of Autoimmune DiseasesNational Human Genome Research Institute (NHGRI)
- RECRUITINGPHASE2NCT07409181A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)Boehringer Ingelheim
- RECRUITINGPHASE3NCT07332481A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseaseEMD Serono Research & Development Institute, Inc.
- RECRUITINGEARLY PHASE1NCT07526350MTS109 in Patients With Refractory Autoimmune DiseasesShanghai Changzheng Hospital
- RECRUITINGEARLY PHASE1NCT07490041Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic DiseasesThe Children's Hospital of Zhejiang University School of Medicine
- RECRUITINGNANCT07470151Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune DiseasesUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology